Latest News and Press Releases

VANCOUVER, British Columbia , Jan. 05, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — PlantX Life Inc. (the “Company” or “PlantX”) (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is pleased to announce...

ATLANTA, GA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Gone are the days of wondering, “What are my child’s developmental milestones?” and “How do I keep my child safe indoors?.” Starting today, parents...

Bedford, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- SynBioBeta’s (SBB) Synthetic Biology Global Conference awarded Conagen the “Best Product of the Year” for its human lactoferrin and non-GMO human...

BEVERLY HILLS, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Mounting scientific evidence is showing that chemicals and toxins used in foods and medicines for preserving, flavoring and packaging may...

Den 30 augusti 2018 meddelade Infant Bacterial Therapeutics AB (publ) ("IBT" eller "Bolaget") att Nasdaq Stockholms bolagskommittée godkände ansökan om upptagande till handel av Bolagets aktier i...

On August 30, 2018, Infant Bacterial Therapeutics AB (publ) (”IBT” or the ”Company”) announced that Nasdaq Stockholm’s Listing Committee had approved the admission of the Company’s shares of series B...

Sellbyville, Delaware, Sept. 03, 2018 (GLOBE NEWSWIRE) -- Global Extracorporeal Membrane Oxygenation Market is poised to surpass USD 357 million by 2024; according to a new research study...

IBT har tidigare kommunicerat planen att initiera studien första halvåret 2018. Förberedelserna för studien har tagit något längre än beräknat och företaget planerar nu påbörja studien under andra...

IBT has previously announced its plan to start the phase 3 study in the first half of 2018. Preparations for the study have taken slightly longer than expected and the Company now plans to initiate...

DAVIS, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Evolve BioSystems, Inc., a leader in advancing infant nutrition and health through restoration of the gut microbiome, announced today a collaboration...